Pharma Distribution Partnerships Actylis recently partnered with Novo Nordisk Pharmatech to distribute cGMP grade Benzalkonium Chloride to pharmaceutical and medical device markets across Canada, Germany, Spain, Portugal, the UK, Ireland, the Nordics, Benelux and France. This demonstrates a credible, regulatory-compliant supply network and demand for critical sanitization materials, offering a pathway to expand similar BKC partnerships with other pharma manufacturers and medical device companies.

Specialty Solvent Expansion Actylis partnered with Aarti Industries to expand PCBTF supply in North America, underscoring the ability to source and supply critical specialty solvents for coatings, electronics, and pharmaceutical manufacturing. This creates cross-sell opportunities with prospective customers needing PCBTF and related solvents while strengthening North American supply resilience.

Sterile Manufacturing Capability Montreal site enhancements added Water for Injection and ISO Class 7 manufacturing space, signaling capacity to produce sterile, high-purity materials for pharma and biotech customers. This enables toll manufacturing or long-term supply agreements with CDMOs and early-stage developers seeking WFI grade water and sterile processing.

Strategic Growth Network Actylis history of growth through mergers and acquisitions, including Pharm Rxchem in 2024 and the CDMO asset sale to Agno Pharma in 2026, indicates a flexible platform for partnerships, co-development, or asset-light supply arrangements with scale advantages in Life Sciences and related chemicals.

Nutritional Materials Focus Actylis Nutrition specializes in mineral amino acid chelates and complexes with a strong emphasis on scientific validation and quality. This capability can be leveraged to target nutraceuticals, dietary supplements, and agriscience customers needing premium mineral ingredients and can form strategic supplier relationships across Life Sciences and specialty chemicals.